Maged Shenouda - Chief Financial Officer at Relmada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Maged Shenouda - trading volume in the past year for Relmada Therapeutics, Inc.

Holdings reported by Maged Shenouda for Relmada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 88.3K $261K $2.95 Sep 11, 2024 Direct
Stock Option (right to buy) 82.1K May 24, 2024 Direct Common Stock

Transactions reported by Maged Shenouda for Relmada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.